SENP1-IN-1
SENP1-IN-1 is a specific deSUMOylation protease 1 (SENP1) inhibitor extracted from patent CN110627860, Compound 29. SENP1-IN-1 is developed for tumor radiosensitivity enhancement[1].
Product Specifications
CAS Number
2416910-69-3
UNSPSC
12352211
Target
E1/E2/E3 Enzyme
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/senp1-in-1.html
Concentration
10mM
Purity
99.55
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC1(C)[C@@H](O)CC[C@]2(C)[C@@]3([H])CC=C4[C@]5([H])[C@@H](C)[C@H](C)CC[C@@](C(NCC(N(CCO)C)=O)=O)5CC[C@](C)4[C@@](C)3CC[C@@]12[H]
Molecular Formula
C35H58N2O4
Molecular Weight
570.85
References & Citations
[1]Li, Yiliang, et al. Preparation of ursolic acid derivatives useful as SENP1 inhibitors and tumor radiosensitizer. CN110627860A.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Vgl4 (VGLL4) (NM_001128219) Human Over-expression Lysate
![FITC Anti-Mouse CD49d Antibody[R1-2]](https://cdn.genprice.uk/products/763/68dd149e061270361e7cfe9c/imageurl/an00422uc.webp)